Structural and Drug Targeting Insights on Mutant p53

Area of Science:

• Molecular Biology
• Biochemistry
• Oncology

Background:

• The p53 protein is crucial for maintaining cell stability and preventing tumor formation.
• Mutations in the TP53 gene are found in approximately 50% of human cancers, leading to altered p53 function and promoting cancer growth.
• Mutant p53 (mutp53) can gain new cancer-promoting functions, making it a significant challenge in cancer therapy.

Purpose of the Study:

• To provide a comprehensive overview of mutant p53 (mutp53) regulation.
• To highlight the structural characteristics of mutp53 and its potential as a therapeutic target.
• To review compounds that can reactivate mutp53, aiming to advance precision cancer therapy.

Main Methods:

• Literature review integrating structural, pharmacological, and biological data on p53.
• Focus on structural studies of wild-type (wt) and mutant p53 (mutp53).
• Analysis of targeting agents designed to restore wt-like function to mutp53.

Main Results:

• Structural studies have significantly advanced the understanding of p53's role in cellular processes and disease.
• Various compounds show potential in restoring wild-type (wt)-like function to mutant p53 (mutp53), though clinical application is pending.
• Understanding mutp53 structure and reactivation mechanisms is crucial for developing novel anticancer drugs.

Conclusions:

• Targeting mutant p53 (mutp53) represents a promising strategy for cancer treatment.
• Further research into mutp53 structural traits and reactivation agents can lead to improved small molecules for precision cancer therapy.
• Developing effective p53-targeting therapies holds potential for significant advancements in treating a wide range of human cancers.